Author

Yu Dai

Institution: Lanzhou University Second Hospital

Observed institution: Lanzhou University Second Hospital

OpenAlex ID: A5127826893

TREM2 in Urological Malignancies and Benign Lesions: Mechanistic Convergence, Functional Heterogeneity, and Translational Perspectives: A Narrative Review

2026 · Yu Dai, Yaqiang Feng, et al. · Cancers · 2

Adjuvant disitamab vedotin plus PD-1 blockade and gemcitabine/cisplatin in high-risk upper tract urothelial carcinoma: a two-stage real-world comparative study

2026 · Cheng Wang, Shuaipeng He, et al. · Frontiers in Immunology · 1

Stage and Age Characterize Distinct, Time-Varying Mortality Pathways in Older Adults With Bladder Cancer: A Population-Based Competing-Risk Study

2026 · Yu Dai, Yaqiang Feng, et al. · Research Square

Commentary: Association of composite dietary antioxidant index with high risk of prostate cancer in middle-aged and elderly men: insights from NHANES

2026 · Yu Dai, Shuangning Liu, et al. · Frontiers in Immunology

Works count: 4

Citation count: 3

H-index: 1

I10-index: